Statute Details
- Title: Pharmacists Registration Act 2007
- Act Code: PRA2007
- Full Title: An Act to establish the Singapore Pharmacy Council, to provide for the registration of pharmacists and for matters connected therewith.
- Type: Act of Parliament (Singapore)
- Current version (as provided): Current version as at 27 Mar 2026
- Revised edition (as provided): 2020 Revised Edition (in operation from 31 Dec 2021)
- Commencement Date: Not specified in the extract (historically: [1 September 2008] shown for the 2008 Revised Edition context)
- Key structure: Part 1 (Preliminary), Part 2 (Singapore Pharmacy Council), Part 3 (Registration), Part 4 (Practice of pharmacy), Part 5 (Specialists Accreditation Board), Part 6 (Disciplinary and Health inquiries), Part 7 (Miscellaneous)
- Core policy focus: Licensing/registration of pharmacists, regulation of “practice of pharmacy”, and disciplinary/health oversight
What Is This Legislation About?
The Pharmacists Registration Act 2007 (“PRA”) is Singapore’s principal statute governing the professional regulation of pharmacists. In plain terms, it creates a regulatory framework to ensure that only appropriately qualified and authorised individuals can practise pharmacy, and that registered pharmacists remain fit to practise through ongoing compliance, disciplinary oversight, and health-related inquiry mechanisms.
The Act establishes the Singapore Pharmacy Council (“Council”) and provides for the registration of pharmacists, including different categories such as full registration, conditional registration, specialist registration, and temporary registration. It also regulates the “practice of pharmacy” by defining what activities amount to practising pharmacy and by prohibiting unauthorised persons from doing so.
Beyond entry into the profession, the PRA provides a structured disciplinary system. Complaints can be made against registered pharmacists, inquiries can lead to disciplinary orders, and separate health processes can address unfitness to practise due to illness or other health-related factors. The statute also includes procedural safeguards such as rights of hearing and avenues for appeal, as well as interim suspension mechanisms to protect the public where necessary.
What Are the Key Provisions?
1) Establishment and functions of the Singapore Pharmacy Council (Parts 2 and 6 context)
Part 2 establishes the Council as a statutory body and sets out its governance. The Council is incorporated and constituted through provisions dealing with its composition, the President, disqualifications for membership, filling vacancies, meetings, quorum, and the appointment of an executive secretary and employees. The Council’s functions are central to the PRA’s regulatory purpose: it administers registration, maintains registers, and oversees professional standards through disciplinary and health processes.
For practitioners, the Council’s role matters because many consequential decisions—such as registration outcomes, amendments to registers, disciplinary findings, and the implementation of orders—are operationalised through Council structures and committees created under the Act.
2) Registration framework: registers, categories, and evidence of qualification (Part 3)
Part 3 is the heart of the PRA’s gatekeeping function. It provides for the appointment of a Registrar, the maintenance of registers, and the mechanisms for different registration statuses.
The Act distinguishes between full registration and conditional registration, and it also provides for registration of specialists and temporary registration. While the extract does not reproduce the detailed eligibility criteria, the structure indicates that the PRA contemplates varying pathways into practice depending on qualification status, experience, or other regulatory considerations.
Section 20 (as listed) addresses evidence of qualification and entry of additional qualifications, which is important for ongoing professional development and for ensuring that a pharmacist’s credentials are reflected in the appropriate register. Sections 21 to 27 then cover the application process, the certificate of registration, and the practising certificate—a key compliance document that authorises practice. The Act also provides for amendments to the appropriate register, removal of names, and restoration where names were removed under specified provisions. Finally, the Registrar’s certificates can serve as evidence (section 27), which is practically significant in disputes or enforcement proceedings.
3) Regulation of “practice of pharmacy” and restrictions on unauthorised practice (Part 4)
Part 4 is designed to protect the public by restricting who may practise pharmacy. The Act prohibits an unauthorised person from acting as a pharmacist (section 28). The definition of “unauthorised person” in the extract is particularly useful: it includes (a) a person who is not a registered pharmacist, and (b) a registered pharmacist who does not have a valid practising certificate and has not been exempted under sections 70 or 71.
This means that registration alone is not necessarily sufficient; the practising certificate is a separate compliance requirement. For legal practitioners, this distinction is often where enforcement turns: a person may be “registered” but still be “unauthorised” if practising certificate requirements are not met.
Part 4 also addresses liability allocation. Section 29 provides for liability of employer (and related persons) where pharmacy practice occurs in contravention of section 28. Section 30 provides for liability of a registered pharmacist for allowing another to act in contravention of section 28. These provisions are important for corporate and employment-related risk: employers and supervising pharmacists may face exposure if they permit unauthorised practice.
Additional prohibitions include: not practising during suspension (section 31), false assumption of specialist title (section 32), and fraudulent registration (section 33). Section 34 requires pharmacists to use only qualifications entered in the register and approved titles. These provisions collectively support the integrity of professional representation and prevent misleading claims to specialist status.
4) Specialists Accreditation Board and specialist titles (Parts 5 and 4)
Part 5 establishes the Specialists Accreditation Board and sets out its functions. The PRA therefore separates the specialist accreditation function from the general registration framework. This is consistent with the Act’s approach to specialist titles: specialist registration is regulated, and false assumption of specialist title is prohibited under section 32.
For practitioners advising on specialist claims (for example, marketing, employment contracts, or disciplinary risk), the key is that specialist status is not merely a professional label; it is a regulated status tied to the statutory framework and the register.
5) Disciplinary and health inquiries: complaints, committees, orders, and appeals (Part 6)
Part 6 provides a comprehensive system for handling allegations and fitness-to-practise concerns. It includes the appointment of a Complaints Panel (section 38), processes for complaints against registered pharmacists (section 39), and inquiry mechanisms through a Complaints Committee (sections 40–41). Where disciplinary action is warranted, the matter proceeds to a Disciplinary Committee (sections 42–46), which can make findings and issue orders.
Crucially, the Act includes a pathway for transfer to a Health Committee (section 44) and provisions addressing unfitness to practise through illness, etc. (section 51). This separation recognises that professional misconduct and health-related unfitness may require different fact-finding and protective measures.
Part 6 also contains appeal rights (section 47) and mechanisms for restoration of names to the appropriate register following disciplinary or health recommendations (sections 48 and 52). For urgent risk management, the Act provides for interim orders via an Interim Orders Committee (sections 53–56), including interim suspension orders and review processes (sections 55–56). Procedurally, the Act includes a right of hearing (section 57) and an application to the General Division of the High Court (section 58). Interim measures are time-bound (section 59), and the Act clarifies that a person suspended under an interim suspension order is not regarded as registered (section 60), which ties back to the “unauthorised person” concept in Part 4.
Finally, Part 6 includes provisions on Council’s ability to appoint legal counsel (section 61) and on recovery of penalties and costs (section 62), which affects the financial consequences of disciplinary outcomes.
How Is This Legislation Structured?
The PRA is organised into seven Parts:
Part 1 (Preliminary) sets out the short title and key definitions, including “practice of pharmacy” and “unauthorised person”.
Part 2 establishes and governs the Singapore Pharmacy Council, including its constitution, meetings, and administrative staffing.
Part 3 creates the registration architecture: registers, categories of registration, applications, certificates, and register maintenance (amendment, removal, and restoration).
Part 4 regulates the actual practice of pharmacy, including prohibitions on unauthorised practice, employer and pharmacist liability, suspension effects, specialist title integrity, and general penalties.
Part 5 establishes the Specialists Accreditation Board and defines its functions.
Part 6 provides the disciplinary and health inquiry regime, including complaints handling, committee structures, findings and orders, interim measures, hearing rights, appeals, and court review.
Part 7 contains miscellaneous provisions, including fees, inspectors/assessors, protection against liability, court jurisdiction, offence composition, exemptions for training and general exemptions, service of documents, regulations, and saving/transitional provisions. The Schedule defines what acts or activities constitute “practice of pharmacy”.
Who Does This Legislation Apply To?
The PRA applies primarily to individuals who seek to practise pharmacy in Singapore and to those already registered as pharmacists. It governs the Singapore Pharmacy Council and its committees, the Specialists Accreditation Board, and the disciplinary/health inquiry bodies that operate under the Act.
In practical terms, the statute affects: (1) registered pharmacists (including obligations tied to practising certificates and restrictions during suspension), (2) unauthorised persons (including persons not registered and registered pharmacists without a valid practising certificate), and (3) employers and supervising pharmacists who may be liable where pharmacy practice occurs in contravention of the Act. It also regulates the use of specialist titles and the integrity of professional representations.
Why Is This Legislation Important?
The PRA is important because it operationalises public protection in the pharmacy sector through a combination of licensing controls, professional integrity rules, and enforceable disciplinary and health processes. For practitioners, the Act is not merely a “registration statute”; it is a comprehensive framework that links registration status to the right to practise, and it connects professional misconduct and health concerns to formal regulatory outcomes.
From an enforcement and compliance perspective, the definition of “unauthorised person” is a critical legal hinge. It makes clear that practising certificate validity is essential. This has direct consequences for employers, locum arrangements, and any scenario where a pharmacist’s practising certificate may lapse, be suspended, or be otherwise invalid. The Act’s provisions on employer liability and pharmacist liability for allowing unauthorised practice reinforce that compliance is not only an individual duty but also a supervisory and organisational responsibility.
From a dispute-resolution standpoint, Part 6’s committee-based disciplinary architecture, interim order regime, and appeal/court review mechanisms provide a structured pathway for managing allegations. The inclusion of interim suspension and the clarification that a suspended person is not regarded as registered underscores the Act’s protective intent: where there is a risk to public safety, the regulatory system can act quickly while still providing procedural safeguards such as rights of hearing and review.
Related Legislation
- Pharmacists Registration Act 2007 (PRA2007) — principal statute
- Subsidiary legislation made under the PRA (e.g., regulations and notifications prescribing matters such as exemptions or prescribed institutions for “Singapore degree”, where applicable)
- General principles of administrative law and court procedure relevant to appeals and High Court applications under Part 6 (where invoked)
Source Documents
This article provides an overview of the Pharmacists Registration Act 2007 for legal research and educational purposes. It does not constitute legal advice. Readers should consult the official text for authoritative provisions.